nial

A/Prof Nial Wheate

Associate Professor of the School of Pharmacy, University of Sydney
Associate Professor Wheate completed a Bachelor of Science (BSc) degree with 1st class honours from the University of New South Wales whilst at the Australian Defence Force Academy. He then completed a Doctor of Philosophy (PhD) in medicinal chemistry under Professor J. Grant Collins. Since then he has worked in the School of Biomedical and Health Sciences at the University of Western Sydney (Australia) and the Strathclyde Institute of Pharmacy and Biomedical Science (Scotland) before taking up a position in the Faculty of Pharmacy at the University of Sydney (Australia) in 2012.

In 2020, Associate Professor Wheate was awarded a Doctor of Science (DSc) from the University of Sydney.

Associate Professor Wheate was previously the Program Director of the pharmacy undergraduate degrees at The University of Sydney and the Head of Cancer Research in the Faculty of Pharmacy.

Awards
The Australian Research Awards 2023, Best in Field (Inorganic Chemistry)
Senior Fellow, Higher Education Academy, 2019
Royal Australian Chemical Institute Nyholm Lecturer, 2018

More from this expert

In an era where chronic pain affects millions worldwide, the search for effective and safe pain relief has never been greater...

Clinical Articles iconClinical Articles

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Clinical Articles iconClinical Articles

Expert explains the evidence linking the asthma drug to depression

Clinical Articles iconClinical Articles

An antidepressant containing a form of the drug ketamine has been added to the PBS, making it much cheaper for the estimated 30,000 Australians with treatment-resistant depression.

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.